Armco Asbestos Training
Contact us 0161 761 4424
Armco Asbestos Training
Want to stay up to date with the latest news from Armco Training on whats happening in the asbestos world? Bookmark this page or subscribe to our Newsletter to get regular news updates from us automatically as they are published.
Asbestos found in hundreds of Derbyshire schools Derbyshire County Council have said that asbestos found in hundreds of Derbyshire schools has already cost them over £400,00 in compensation claims. And those costs are set to rise as more cases are expected to be dealt with. According to the figures gathered, over 200 schools in the county […]
Read the full article | Published Nov 15, 2016
New study reveals women may be more vulnerable to mesothelioma People who are exposed to asbestos during their working life are more likely to develop an asbestos related disease such as mesothelioma. People who work in industries such as construction, ship building, automotive and manufacturing have shown strong links to developing asbestos cancer, mainly men, […]
Read the full article | Published Oct 04, 2016
New study reveals ovarian cancer drug may help mesothelioma sufferers Swiss researchers are raising hopes for asbestos victims and their families as a new study reveals ovarian cancer drug may help mesothelioma sufferers. The researchers have carried out two different studies to date using a drug that would normally be used to treat ovarian cancer. The […]
Read the full article | Published Aug 17, 2016
Appeal for colleagues of a man who died from Mesothelioma A family have launched an appeal for colleagues of a man who died from Mesothelioma to get in touch with them, so that they are able to work out how their father contracted the deadly asbestos related disease. Mr Mick Torr died at the age […]
Read the full article | Published Aug 15, 2016
Asbestos cancer victims given new hope A new drug that has been developed by scientists is giving asbestos cancer victims new hope as it is found to beat the deadly cancer, mesothelioma, which is linked to asbestos. 94 per cent of mesothelioma patients who took part in a recent clinical trial responded well to the drug. […]
Read the full article | Published Jul 11, 2016
